학술논문

Plants as an innovative and accelerated vaccine-manufacturing solution: a plant-based expression system could provide greater speed and capacity than other recombinant technologies at a comparatively low cost
Document Type
Periodical
Source
Biopharm International. May, 2011, Vol. 24 Issue 5, ps27, 4 p.
Subject
North Carolina
Canada
Language
English
ISSN
1542-166X
Abstract
ABSTRACT Medicago has developed a proprietary plant-based manufacturing platform that produces vaccines made of influenza antigen scaffolds (i.e., viruslike particles) that are currently in clinical trials in Canada and the [...]